Back

Aortic valve hemodynamic deterioration after transcatheter aortic valve implantation (TAVI) and its association with anti-thrombotic therapy.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Trans-catheter valve interventions and their complications Aortic valve surgery ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Claudio Guerreiro

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

10 More presentations in this session

Presentation thumbnail
Outcomes in a resource-constrained economy: results from the multi-centre South African SHARE-TAVI registry
Professor H. Weich (Cape Town, ZA)
Abstract Slides
Presentation thumbnail
Risk factors and outcome of postoperative delirium after transcatheter aortic valve replacement
Doctor P. Stachon (Freiburg, DE)
Abstract
Presentation thumbnail
Impact of reduced left ventricular ejection fraction on outcomes after transcatheter aortic valve implantation
Doctor A. Munoz Garcia (Malaga, ES)
Abstract Slides
Presentation thumbnail
Prognostic value of heart failure before and during the first year after TAVI. Factors determining heart failure after TAVI.
Miss R. GONZALEZ FERREIRO (Vigo, ES)
Abstract Slides
Presentation thumbnail
Incidence, predictive and prognostic factors of hospitalization for cardiac heart failure in patients implanted with TAVR
Professor E. Durand (Rouen, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Trans-catheter valve interventions and their complications

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources